Effects of Shenfu Injection on prostacyclin, thromboxane A2 and activities of ATPases in rats exposed to hepatic ischemia-reperfusion injury
Author:
- 15 July 2007
- journal article
- abstracts
- Published by Journal of Chinese Integrative Medicine Press in Journal of Chinese Integrative Medicine
- Vol. 5 (4) , 427-431
Abstract
To explore the effects of Shenfu Injection on prostacyclin, thromboxane A2 and the activities of ATPases in rats exposed to hepatic ischemia-reperfusion injury. Twenty-four male Wistar rats weighing 200-250 g were randomly divided into two groups: Shenfu Injection (SF)-treated group (rats were treated with Shenfu Injection of 10 ml/kg through intraperitoneal injection) and untreated group (rats were administered with normal saline at the same dose and served as a control group). Hepatic ischemia was caused by Pringle's maneuver and lasted for fifteen minutes, and then one-hour or three-hour reperfusion was performed. Venous blood samples for the measurement of thromboxane B(2) (TXB(2)) and 6-keto-prostaglandin F(1 alpha)(6-keto-PGF(1 alpha)) were collected three hours after reperfusion. Liver tissue samples were collected one hour or three hours after reperfusion for the measurement of Na(+)-K(+)-ATPase and Ca(+)-Mg(+)-ATPase and for morphological studies. Plasma TXB(2) was lower in the SF-treated group than that in the untreated group after three-hour reperfusion (P>0.05), while 6-keto-PGF(1 alpha) was higher in the SF-treated group than that in the untreated group (P>0.05). The ratio of TXB(2) and 6-keto-PGF(1 alpha) was significantly lower in the SF-treated group than that in the untreated group (P<0.05). The activities of Na(+)-K(+)-ATPase and Ca(+)-Mg(+)-ATPase in the SF-treated group were improved obviously. A three-hour reperfusion after fifteen-minute ischemia caused important hepatic histological alterations. Marked structural abnormalities were observed in the untreated group, such as massive hepatocyte swelling, necrosis, mitochondria edema and vacuolar changes. In the SF-treated group, hepatic tissue injury was reduced significantly. Shenfu Injection protects hepatic tissue from ischemia-reperfusion injury, and such protective effects are achieved by decreasing the ratio of thromboxane A(2) and prostacyclin, and increasing the activities of Na(+)-K(+)-ATPase and Ca(+)-Mg(+)- ATPase.Keywords
This publication has 8 references indexed in Scilit:
- Roles of Prostaglandin I 2 and Thromboxane A 2 in Cardiac Ischemia-Reperfusion InjuryCirculation, 2001
- Effects of Low-Dose Beraprost Sodium, a Stable Prostaglandin I2 Analogue, on Reperfusion Injury to Rabbit LungsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Impact of ischemia-reperfusion injury on dimensional changes of hepatic microvesselsZeitschrift für Die Gesamte Experimentelle Medizin, 1998
- Bradykinin Mediation of Ca2+-Activated K+Channels Regulates Coronary Blood Flow in Ischemic MyocardiumCirculation, 1997
- Iloprost dilates rat small arteries: role of K(ATP)- and K(Ca)-channel activation by cAMP-dependent protein kinaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- Inhibition of Thromboxane A2Activity during Warm Ischemia of the LiverJournal of Surgical Research, 1996
- Pentoxifylline protects splanchnic prostacyclin synthesis during mesenteric ischemia/reperfusionProstaglandins, 1994
- Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.Circulation Research, 1992